Cancer Services

When it comes to cancer, early detection and treatment can translate into prevention and cure. Our practice provide services to screen for colon cancer, breast cancer, prostate cacner and other forms of cancer. We are located and work closely with the Ireland Cancer center physiicans and staff.

Breast Cancer Screening

Screening for Breast Cancer

Release Date: November 2009
Updated: December 2009

---

This topic page summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on breast cancer screening.

Summary of Recommendations

---

Summary of Recommendations

• The USPSTF recommends biennial screening mammography for women aged 50 to 74 years.
  Grade: B recommendation.
• The decision to start regular, biennial screening mammography before the age of 50 years should be an individual one and take patient context into account, including the patient's values regarding specific benefits and harms.
  Grade: C recommendation.
• The USPSTF concludes that the current evidence is insufficient to assess the additional benefits and harms of screening mammography in women 75 years or older.
  Grade: I Statement.
• The USPSTF recommends against teaching breast self-examination (BSE).
  Grade: D recommendation.
• The USPSTF concludes that the current evidence is insufficient to assess the additional benefits and harms of clinical breast examination (CBE) beyond screening mammography in women 40 years or older.
  Grade: I Statement.
• The USPSTF concludes that the current evidence is insufficient to assess the additional benefits and harms of either digital mammography or magnetic resonance imaging (MRI) instead of film mammography as screening modalities for breast cancer.
  Grade: I Statement.

 

On December 4, 2009, the USPSTF unanimously voted to update the language of their recommendation regarding women under 50 years of age to clarify their original and continued intent.

 

Colon Cancer Screening

Screening for Colorectal Cancer

Release Date: October 2008

The U.S. Preventive Services Task Force recommendation on Screening for Colorectal Cancer was published on October 7, 2008, by the Annals of Internal Medicine as an early online release. The print publication in Annals occurred on November 4, 2008.

---

This topic page summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on screening for colorectal cancer.

Summary of Recommendations / Supporting Documents

Summary of Recommendations

• The USPSTF recommends screening for colorectal cancer (CRC) using fecal occult blood testing, sigmoidoscopy, or colonoscopy, in adults, beginning at age 50 years and continuing until age 75 years. The risks and benefits of these screening methods vary.  
  Grade: A Recommendation.
• The USPSTF recommends against routine screening for colorectal cancer in adults age 76 to 85 years. There may be considerations that support colorectal cancer screening in an individual patient.
  Grade: C Recommendation.
• The USPSTF recommends against screening for colorectal cancer in adults older than age 85 years.
  Grade: D Recommendation.
• The USPSTF concludes that the evidence is insufficient to assess the benefits and harms of computed tomographic colonography and fecal DNA testing as screening modalities for colorectal cancer.
  Grade: I Statement.

 

Supporting Documents

Screening for Colorectal Cancer, October 2008
Recommendation Statement (PDF File, 245 KB; PDF Help)
Clinical Summary (PDF FIle, 51 KB; PDF Help)
Supporting Article—Decision Analysis (PDF File, 290 KB; PDF Help)
Supporting Article—Updated Systematic Review (PDF File, 320 KB; PDF Help)
Evidence Synthesis, Part 1 (PDF File, 3 MB; PDF Help)
Evidence Synthesis, Part 2 (PDF File, 790 KB; PDF Help)

Research Supplement: CRC Screening Implications in Primary Care

 

Prostate cancer screening

Screening for Prostate Cancer

Release Date: August 2008

This topic page summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on screening for prostate cancer.

Summary of Recommendations / Supporting Documents / Published Comments and Response

Summary of Recommendations

• The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of prostate cancer screening in men younger than age 75 years.
  Grade: I Statement.
• The USPSTF recommends against screening for prostate cancer in men age 75 years or older.
  Grade: D Recommendation.

 

Supporting Documents

Screening for Prostate Cancer, August 2008

Recommendation Statement (PDF File, 210 KB; PDF Help)
Supporting Article (PDF File, 195 KB; PDF Help)
Evidence Synthesis (PDF File, 420 KB; PDF Help)
Clinical Summary (PDF File, 115 KB; PDF Help)
Video: How to Talk with Your Patients When Evidence Is Insufficient (3:40 minutes, Windows Media®)